Beyond Biotech podcast 29: Janssen, Knowledge Gate
This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince,…
This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince,…
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA)…
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research…
Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral…
A treatment for chronic graft versus host disease in children aged one year and older…
A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday…
U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate…
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
Public and private organizations across Europe will pool their resources in an €80M project to…
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could…